vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and ENERGIZER HOLDINGS, INC. (ENR). Click either name above to swap in a different company.

ENERGIZER HOLDINGS, INC. is the larger business by last-quarter revenue ($778.9M vs $487.7M, roughly 1.6× CLOVER HEALTH INVESTMENTS, CORP.). ENERGIZER HOLDINGS, INC. runs the higher net margin — -0.4% vs -10.1%, a 9.7% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 6.5%). ENERGIZER HOLDINGS, INC. produced more free cash flow last quarter ($124.2M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 8.4%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Energizer Holdings, Inc. is an American manufacturer and one of the world's largest manufacturers of batteries, headquartered in Clayton, Missouri. It produces batteries under the Energizer, Ray-O-Vac, Varta, and Eveready brand names and formerly owned several personal care businesses until it separated that side of the business into a new company called Edgewell Personal Care in 2015.

CLOV vs ENR — Head-to-Head

Bigger by revenue
ENR
ENR
1.6× larger
ENR
$778.9M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+38.3% gap
CLOV
44.7%
6.5%
ENR
Higher net margin
ENR
ENR
9.7% more per $
ENR
-0.4%
-10.1%
CLOV
More free cash flow
ENR
ENR
$193.2M more FCF
ENR
$124.2M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
8.4%
ENR

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CLOV
CLOV
ENR
ENR
Revenue
$487.7M
$778.9M
Net Profit
$-49.3M
$-3.4M
Gross Margin
32.9%
Operating Margin
-10.1%
-0.6%
Net Margin
-10.1%
-0.4%
Revenue YoY
44.7%
6.5%
Net Profit YoY
-123.2%
-115.2%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
ENR
ENR
Q4 25
$487.7M
$778.9M
Q3 25
$496.6M
$832.8M
Q2 25
$477.6M
$725.3M
Q1 25
$462.3M
$662.9M
Q4 24
$337.0M
$731.7M
Q3 24
$331.0M
$805.7M
Q2 24
$356.3M
$701.4M
Q1 24
$346.9M
$663.3M
Net Profit
CLOV
CLOV
ENR
ENR
Q4 25
$-49.3M
$-3.4M
Q3 25
$-24.4M
$34.9M
Q2 25
$-10.6M
$153.5M
Q1 25
$-1.3M
$28.3M
Q4 24
$-22.1M
$22.3M
Q3 24
$-9.2M
$47.6M
Q2 24
$7.4M
$-43.8M
Q1 24
$-19.2M
$32.4M
Gross Margin
CLOV
CLOV
ENR
ENR
Q4 25
32.9%
Q3 25
36.6%
Q2 25
55.1%
Q1 25
39.1%
Q4 24
36.8%
Q3 24
24.5%
38.1%
Q2 24
30.3%
39.5%
Q1 24
23.6%
38.2%
Operating Margin
CLOV
CLOV
ENR
ENR
Q4 25
-10.1%
-0.6%
Q3 25
-4.9%
6.4%
Q2 25
-2.2%
22.6%
Q1 25
-0.3%
5.5%
Q4 24
-6.4%
4.1%
Q3 24
-2.7%
7.4%
Q2 24
2.0%
-8.2%
Q1 24
-6.5%
6.4%
Net Margin
CLOV
CLOV
ENR
ENR
Q4 25
-10.1%
-0.4%
Q3 25
-4.9%
4.2%
Q2 25
-2.2%
21.2%
Q1 25
-0.3%
4.3%
Q4 24
-6.6%
3.0%
Q3 24
-2.8%
5.9%
Q2 24
2.1%
-6.2%
Q1 24
-5.5%
4.9%

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
ENR
ENR
Cash + ST InvestmentsLiquidity on hand
$78.3M
$214.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$141.3M
Total Assets
$541.0M
$4.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
ENR
ENR
Q4 25
$78.3M
$214.8M
Q3 25
$236.2M
Q2 25
$171.1M
Q1 25
$139.3M
Q4 24
$194.5M
$195.9M
Q3 24
$288.0M
$216.9M
Q2 24
$254.8M
$146.7M
Q1 24
$208.3M
$158.1M
Total Debt
CLOV
CLOV
ENR
ENR
Q4 25
Q3 25
$3.4B
Q2 25
$3.2B
Q1 25
$3.2B
Q4 24
$3.1B
Q3 24
$3.2B
Q2 24
$3.2B
Q1 24
$3.2B
Stockholders' Equity
CLOV
CLOV
ENR
ENR
Q4 25
$308.7M
$141.3M
Q3 25
$340.9M
$169.9M
Q2 25
$344.2M
$183.2M
Q1 25
$336.1M
$133.9M
Q4 24
$341.1M
$140.6M
Q3 24
$342.2M
$135.8M
Q2 24
$324.9M
$123.4M
Q1 24
$292.5M
$191.3M
Total Assets
CLOV
CLOV
ENR
ENR
Q4 25
$541.0M
$4.4B
Q3 25
$559.7M
$4.6B
Q2 25
$575.0M
$4.5B
Q1 25
$583.7M
$4.2B
Q4 24
$580.7M
$4.2B
Q3 24
$653.0M
$4.3B
Q2 24
$674.2M
$4.2B
Q1 24
$671.8M
$4.3B
Debt / Equity
CLOV
CLOV
ENR
ENR
Q4 25
Q3 25
20.28×
Q2 25
17.57×
Q1 25
23.56×
Q4 24
22.17×
Q3 24
23.51×
Q2 24
26.04×
Q1 24
16.86×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
ENR
ENR
Operating Cash FlowLast quarter
$-66.9M
$149.5M
Free Cash FlowOCF − Capex
$-69.0M
$124.2M
FCF MarginFCF / Revenue
-14.1%
15.9%
Capex IntensityCapex / Revenue
0.4%
3.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$145.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
ENR
ENR
Q4 25
$-66.9M
$149.5M
Q3 25
$12.1M
$61.5M
Q2 25
$5.4M
$21.4M
Q1 25
$-16.3M
$-12.8M
Q4 24
$34.8M
$77.0M
Q3 24
$50.0M
$168.9M
Q2 24
$44.8M
$45.8M
Q1 24
$25.9M
$36.8M
Free Cash Flow
CLOV
CLOV
ENR
ENR
Q4 25
$-69.0M
$124.2M
Q3 25
$11.4M
$46.7M
Q2 25
$4.8M
$7.9M
Q1 25
$-16.5M
$-33.8M
Q4 24
$33.3M
$42.4M
Q3 24
$49.6M
$141.5M
Q2 24
$44.4M
$27.3M
Q1 24
$25.5M
$10.3M
FCF Margin
CLOV
CLOV
ENR
ENR
Q4 25
-14.1%
15.9%
Q3 25
2.3%
5.6%
Q2 25
1.0%
1.1%
Q1 25
-3.6%
-5.1%
Q4 24
9.9%
5.8%
Q3 24
15.0%
17.6%
Q2 24
12.5%
3.9%
Q1 24
7.3%
1.6%
Capex Intensity
CLOV
CLOV
ENR
ENR
Q4 25
0.4%
3.2%
Q3 25
0.1%
1.8%
Q2 25
0.1%
1.9%
Q1 25
0.0%
3.2%
Q4 24
0.5%
4.7%
Q3 24
0.1%
3.4%
Q2 24
0.1%
2.6%
Q1 24
0.1%
4.0%
Cash Conversion
CLOV
CLOV
ENR
ENR
Q4 25
Q3 25
1.76×
Q2 25
0.14×
Q1 25
-0.45×
Q4 24
3.45×
Q3 24
3.55×
Q2 24
6.04×
Q1 24
1.14×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

ENR
ENR

Alkaline Batteries$666.5M86%
Auto Care$93.7M12%
Lights$18.7M2%

Related Comparisons